| Net sales | 46,606a | 47,637a |
| Cost of goods sold | -21,270a | -19,749a |
| Gross profit | 25,336a | 27,888a |
| Selling expenses | -13,364a | -12,482a |
| Research and development expenses | -6,209a | -5,371a |
| General administration expenses | -2,574a | -2,453a |
| Other operating income | 1,779a | 1,897a |
| Other operating expenses | -5,039a | -8,867a |
| EBIT | -71a | 612a |
| Equity-method income (loss) | -132a | -162a |
| Financial income | 545a | 601a |
| Financial expenses | -2,676a | -2,672a |
| Financial result | -2,263a | -2,233a |
| Income before income taxes | -2,334a | -1,621a |
| Income taxes | -212a | -1,321a |
| Income after income taxes | -2,546a | -2,942a |
| Of which attributable to noncontrolling interest | 6a | -1a |
| Of which attributable to Bayer AG stockholders (net income) | -2,552a | -2,941a |